FDA Inspection 1227866 — Goodman Co., Ltd. Goodman Research Center / Goodman Medical Innovation Center
The FDA completed an inspection of Goodman Co., Ltd. Goodman Research Center / Goodman Medical Innovation Center on January 25, 2024 in Seto. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 25, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Seto (Japan)